Progressive Care Reports Second Quarter Status Update
MIAMI, FL - July 14, 2017 - InvestorsHub NewsWire
- Progressive Care Inc. (OTC
PINK: RXMD), through its subsidiaries Smart Medical Alliance,
Inc. and PharmCo, LLC, is a South Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, the sale of anti-retroviral medications,
medication therapy management (MTM), and the supply of prescription
medications to long term care facilities, administration and
practice management, utilization management, quality assurance, EHR
Implementation, billing and coding, health practice risk
management, announces $1.7 million in net revenues for June
2017.
PharmCo filled nearly 19,000 prescriptions and realized revenues
of over $1.7 million, which represents over a 3% increase over the
same month last year. The company is pursuing every avenue of
growth, including expanded marketing in Palm Beach County,
development of proprietary digital interfaces, and the creation of
healthcare compliance and adherence solutions for primary
healthcare providers.
The Company is currently undertaking a restructuring of Smart
Medical Alliance to adjust to the changes in the healthcare
environment. This includes securing new management for the Company
and the development of new programs that provide custom solutions
for healthcare practitioners.
Progressive Care is continuing a growth and development strategy
as a public company through its ongoing relationship with Boustead
Securities. The company is actively engaged in communications about
prospective merger and acquisition opportunities.
We continue to push forward on all cylinders, stated S. Parikh
Mars, CEO. We know we are on the right path as we evolve as
healthcare practitioners in the pharmacy space.
About Progressive Care
Progressive Care, Inc. (OTC
PINK: RXMD), through its subsidiary PharmCo, LLC, is a South
Florida health services organization and provider of prescription
pharmaceuticals specializing in health practice risk management,
compounded medications, the sale of anti-retroviral medications and
related medication therapy management, and the supply of
prescription medications to long term care facilities.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Companys
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words anticipate, believe, estimate, upcoming, plan,
target, intend and expect and similar expressions, as they relate
to Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development